Trials / Unknown
UnknownNCT02502656
RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer
RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer: Concordance With the "Standard" Testing Method From Tumor Tissue and Review of Associated Timelines and Costs
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 425 (estimated)
- Sponsor
- Association des Gastroentérologues Oncologues · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the concordance of RAS mutation detection between the results obtained from circulating tumor DNA and those obtained with the "standard" method (testing from tumor tissue).
Conditions
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2015-07-20
- Last updated
- 2016-11-17
Locations
14 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02502656. Inclusion in this directory is not an endorsement.